To determine the clinical utility of blood tests as a screening tool for metabolic abnormalities in patients with kidney stone disease.
Clinical and biochemical data from 709 patients attending the Oxford University Hospitals NHS Foundation Trust for assessment and treatment of kidney stones was prospectively collected between April 2011 and February 2017.